Psoriasis results in long-term inflammation in the body. This inflammation stiffens and narrows the arteries, raising the risk of high blood pressure, heart attack, and stroke. Read on. , Health News ...

PRNewswire/ -- ixlayer, a leading cloud-based healthtech platform, with Ipsos, a global leader in market research, have released findings from the inaugural research report, " ixlayer ixInsights 2025: ...

With discussions on the correct frequency of showering, study debunk common notions around daily showers. Here's everything you need to know.

Struggling with dark spots? Learn what causes hyperpigmentation, how to prevent it, and the best treatments—from skincare ...

Proprietary master cell bank of fibroblast-based spheroids product candidate, CYWC628, completed in accordance with Good Manufacturing Practices ...

A panelist discusses how new data from the 2025 American Academy of Dermatology Annual Meeting (AAD 2025) demonstrates tildrakizumab’s efficacy in treating nail psoriasis, with the 100-mg dose showing ...

Post-hoc analyses of the EFFISAYIL 2 trial revealed improvements in Psoriasis Symptom Scale (PSS), Pain Visual Analog Scale ...

According to board-certified dermatologist with MDCS Dermatology, Dr. Brendan Camp, this is because urea is both a humectant ...

Dr. Reddy's inks collaboration deal with Bio-Thera to develop and commercialize proposed biosimilar candidates of J&J's Stelara and Simponi in Southeast Asia.